Cover
Cover | Nov. 06, 2022 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 06, 2022 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 001-39717 |
Entity Registrant Name | LIXTE BIOTECHNOLOGY HOLDINGS, INC. |
Entity Central Index Key | 0001335105 |
Entity Tax Identification Number | 20-2903526 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 680 East Colorado Boulevard |
Entity Address, Address Line Two | Suite 180 |
Entity Address, City or Town | Pasadena |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 91101 |
City Area Code | (631) |
Local Phone Number | 830-7092 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Common Stock, par value $0.0001 per share | |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | LIXT |
Security Exchange Name | NASDAQ |
Warrants to Purchase Common Stock, par value $0.0001 per share | |
Title of 12(b) Security | Warrants to purchase Common Stock, par value $0.0001 per share |
Trading Symbol | LIXTW |
Security Exchange Name | NASDAQ |